Literature DB >> 17679024

Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity?

Erica Tozawa1, Yoichi Ajioka, Hidenobu Watanabe, Ken Nishikura, Gen Mukai, Takeyasu Suda, Tsunehisa Kanoh, Katsuyoshi Hatakeyama.   

Abstract

Mucinous carcinoma of the colorectum is conventionally defined as carcinoma with an interstitial mucus component (MC) that occupies more than 50% of the tumor tissue. To examine the validity of this definition, we quantified the ratio between the area of MC and the total area of carcinoma (MC ratio) in 152 advanced colorectal carcinomas, and investigated whether MUC1, MUC2 and MUC5AC mucin expression, frequency of p53 overexpression, and peritumoral lymphocytic infiltration (PLI) of tumors differ in the MC ratio. Samples were classified into MC ratios of >50% (n=30), 10-50% (n=24), <10% (n=22), and 0% (n=76). Carcinomas with MC commonly possessed the MUC2+ phenotype (90.9-100%), and 76.6-83.3% possessed either the MUC2+/MUC5AC+/MUC1+ or the MUC2+/MUC5AC-/MUC1+ phenotype. Carcinoma without MC (MC ratio of 0%) was typically the MUC2- phenotype (89.5%). Frequencies of p53 overexpression of carcinomas with MC were significantly lower compared to those without MC (21-27% vs. 55%). PLI was observed in 0-4% of carcinomas with MC, but was observed in 17% of carcinomas without MC. These results indicate that colorectal carcinomas with MC can be grouped together as goblet cell type (MUC2+) carcinoma. These data also suggest that such carcinomas may have a common genetic background and alteration of immune responsiveness. Therefore, separately classifying carcinomas with an MC ratio of more than 50% as an independent histological type may be invalid, and re-evaluation of the histological classification of colorectal carcinoma may be required.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17679024     DOI: 10.1016/j.prp.2007.04.013

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

1.  Clinicopathological Significance of Mucin 2 Immuno-histochemical Expression in Colorectal Cancer: A Meta-Analysis.

Authors:  Li Li; Pei-Lin Huang; Xiao-Jin Yu; Xiao-Dong Bu
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

Review 2.  The molecular background of mucinous carcinoma beyond MUC2.

Authors:  Niek Hugen; Michiel Simons; Altuna Halilović; Rachel S van der Post; Anna J Bogers; Monica Aj Marijnissen-van Zanten; Johannes Hw de Wilt; Iris D Nagtegaal
Journal:  J Pathol Clin Res       Date:  2014-11-05

3.  C-kit signaling promotes proliferation and invasion of colorectal mucinous adenocarcinoma in a murine model.

Authors:  Jun Tan; Shu Yang; Ping Shen; Haimei Sun; Jie Xiao; Yaxi Wang; Bo Wu; Fengqing Ji; Jihong Yan; Hong Xue; Deshan Zhou
Journal:  Oncotarget       Date:  2015-09-29

4.  SCF/c-KIT Signaling Increased Mucin2 Production by Maintaining Atoh1 Expression in Mucinous Colorectal Adenocarcinoma.

Authors:  Ping Shen; Shu Yang; Haimei Sun; Guilan Li; Bo Wu; Fengqing Ji; Tingyi Sun; Deshan Zhou
Journal:  Int J Mol Sci       Date:  2018-05-22       Impact factor: 5.923

Review 5.  Colon mucus in colorectal neoplasia and beyond.

Authors:  Alexandre Loktionov
Journal:  World J Gastroenterol       Date:  2022-08-28       Impact factor: 5.374

6.  A Purified Aspartic Protease from Akkermansia Muciniphila Plays an Important Role in Degrading Muc2.

Authors:  Xin Meng; Wencheng Wang; Tianqi Lan; Wanxin Yang; Dahai Yu; Xuexun Fang; Hao Wu
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.